Better pay for clinical trial participants: in conversation with Gunnar Esiason
Gunnar Esiason, a rare disease patient advocate, shares his views on compensating patients for their contribution to clinical development.
Gunnar Esiason, a rare disease patient advocate, shares his views on compensating patients for their contribution to clinical development.